Celcuity Inc. share price logo

Celcuity Inc.

NASDAQ: CELC

Mid Cap

$92.78

-0.47

(-0.50%)

as on

Celcuity Inc. Stock Performance

as on August 8, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $90.45
    $95.16
    downward going graph

    2.51%

    Downside

    2.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $42.89
    $151.02
    downward going graph

    53.78%

    Downside

    62.77%

    Upside

    downward going graph

Celcuity Inc. share price movements today

Previous Close
$93.25
Open
$94.00
Volume
428.3K
Day's Low - High
$90.45 - $95.16
52 Week Low - High
$42.89 - $151.02

Celcuity Inc. Historical Returns

1 Month Return
-13.32 %
3 Month Return
-28.85 %
1 Year Return
+ 103.25 %
3 Year Return
+ 832.5 %
5 Year Return
+ 353.11 %

Celcuity Inc. Stock Fundamentals & Key Indicators

Check Celcuity Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5B

EPS (TTM)

-3.77

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-275.17%

Celcuity Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Celcuity Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.5B353.11%NA0.00%NA
BUY$41.9B624.31%NA0.00%NA
BUY$122.9B141.53%27.8535.00%NA
BUY$79.1B25.76%18.8327.87%0.48%

Stock Returns calculator for Celcuity Inc. Stock including INR - Dollar returns

The Celcuity Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Celcuity Inc. investment value today

Current value as on today

₹2,19,617

Returns

₹1,19,617

(+119.62%)

Returns from Celcuity Inc. Stock

₹1,02,223 (+102.22%)

Dollar Impact

₹17,394 (+17.39%)

Analyst Recommendation on Celcuity Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Celcuity Inc.. Average target price of $163.54

Celcuity Inc. Share Price Target

Get share price movements and forecasts by analysts on Celcuity Inc..

What analysts predicted

43.27%UPSIDE

Target Price

$163.54

Current Price

$92.78

Analyzed by

12 Analysts

Target

$163.54

Celcuity Inc. target price $163.54, a slight upside of 43.27% compared to current price of $92.78. According to 12 analysts rating.

Indian Investors' Interest in Celcuity Inc. Stock

Investment in Celcuity Inc. Shares on INDmoney has grown by 109.80% in the last 30 days, indicating increased investment activity.

Time period: to

Change:109.80% versus previous 30 day period

Search interest for Celcuity Inc. Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-16% versus previous 30 day period

Celcuity Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
-
-
0
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-18
-21
-23
-29
-36
-36
-45
-43
-50
-52
Net Profit Margin
-8207.55%
0.00%
0.00%
0.00%
-30205.89%
0.00%
0.00%
-28444.16%
0.00%
0.00%

Celcuity Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-6
-7
-7
-9
-29
-40
-63
-111
-177
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-114962.34%

Global Institutional Holdings in Celcuity Inc.

Funds
Holdings
Perceptive Advisors LLC
6.41%
Vanguard Capital Management, LLC
3.66%
Eventide Asset Management, LLC
3.27%
UBS Group AG
1.77%
Morgan Stanley - Brokerage Accounts
2.76%

Celcuity Inc. News & Key Events

  • img

    Today's Timeline - 04 May

    Mon, 04:35 PM

    -

    Celcuity shares surged nearly 18% after positive Phase 3 trial results for gedatolisib in advanced breast cancer.

Insights on Celcuity Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CELC has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CELC stock has moved up by 103.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 465.2% return, outperforming this stock by 362.0%

About Celcuity Inc.

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
OrganisationCelcuity Inc.
Headquarters2800 Campus Drive, Minneapolis, MN, United States, 55441
IndustryBiotechnology
CEOMr. Brian F. Sullivan
E-voting on sharesClick here to vote

Key Management of Celcuity Inc.

Name

Title

Mr. Eldon C. Mayer III, M.B.A.

Chief Commercial Officer

Mr. Brian F. Sullivan

Co-Founder, Chairman & CEO

Dr. Lance G. Laing Ph.D.

Co-Founder, Chief Science Officer, VP, Secretary & Director

Ms. Vicky Hahne CPA

Chief Financial Officer

Ms. Jodi Sievers

Head of Investor Relations & Corporate Communications

Mr. Brent Eilefson

General Counsel

Ms. Sheri Smith

Acting Head of Clinical Operations

Mr. Igor Gorbatchevsky M.D.

Chief Medical Officer

FAQs

What is Celcuity Inc. share price today?

Celcuity Inc. share price today is $92.78 as on at the close of the market. Celcuity Inc. share today touched a day high of $95.16 and a low of $90.45.

What is the 52 week high and 52 week low for Celcuity Inc. share?

Celcuity Inc. share touched a 52 week high of $151.02 on and a 52 week low of $42.89 on . Celcuity Inc. stock price today i.e. is closed at $92.78,which is 38.56% down from its 52 week high and 116.35% up from its 52 week low.

What is Celcuity Inc.'s market capitalisation today?

Celcuity Inc. market capitalisation is $0.00T as on .

How to invest in Celcuity Inc. Stock (CELC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Celcuity Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celcuity Inc. Shares that will get you 0.0162 shares as per Celcuity Inc. share price of $92.78 per share as on August 8, 2026 at 8:46 am IST.

What is the minimum amount required to buy Celcuity Inc. Stock (CELC) from India?

Indian investors can start investing in Celcuity Inc. (CELC) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Celcuity Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Celcuity Inc. share’s latest price of $92.78 as on August 8, 2026 at 8:46 am IST, you will get 0.1078 shares of Celcuity Inc.. Learn more about fractional shares .

What are the returns that Celcuity Inc. has given to Indian investors in the last 5 years?

Celcuity Inc. stock has given 353.11% share price returns and 27.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?